BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6182782)

  • 61. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

  • 63. The clinical significance of titered antinuclear antibodies.
    Ritchie RF
    Arthritis Rheum; 1967 Dec; 10(6):544-52. PubMed ID: 4864485
    [No Abstract]   [Full Text] [Related]  

  • 64. Antinuclear antibodies. I. Patterns of nuclear immunofluorescence.
    Burnham TK; Bank PW
    J Invest Dermatol; 1974 May; 62(5):526-34. PubMed ID: 4595992
    [No Abstract]   [Full Text] [Related]  

  • 65. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of mouse liver sections and cultured mouse fibroblasts as substrates for the detection of antinuclear antibodies.
    Lubiniecki AS
    Am J Clin Pathol; 1976 Nov; 66(5):892-8. PubMed ID: 790937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibodies to double-stranded DNA. A comparison of the indirect immunofluorescent test using crithidia luciliae and the DNA-binding assay.
    Deegan MJ; Walker SE; Lovell SE
    Am J Clin Pathol; 1978 Jun; 69(6):599-604. PubMed ID: 352134
    [No Abstract]   [Full Text] [Related]  

  • 69. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 70. [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study].
    Martínez-Cordero E; Burgos-Vargas R; Herrera-Esparza R; Reyes PA
    Rev Invest Clin; 1983; 35(4):273-7. PubMed ID: 6369466
    [No Abstract]   [Full Text] [Related]  

  • 71. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
    Beutner EH; Krasny SA; Chorzelski TP; Rodnan G; Jablonska S; Kumar V
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):289-95. PubMed ID: 3882784
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
    Kleinsmith DM; Heinzerling RH; Burnham TK
    Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [An immunofluorescence method for detection of anti-DNA-antibodies (author's transl)].
    Helmke K; Wölke U; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):162-71. PubMed ID: 4283272
    [No Abstract]   [Full Text] [Related]  

  • 74. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay.
    Bayer PM; Bauerfeind S; Bienvenu J; Fabien N; Frei PC; Gilburd B; Heide KG; Hoier-Madsen M; Meroni PL; Monier JC; Monneret G; Panzeri P; Shoenfeld Y; Spertini F; Wiik A
    J Autoimmun; 1999 Aug; 13(1):89-93. PubMed ID: 10441172
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Analysis of antinuclear antibodies by fluorescent antibody technic using tissue culture cells].
    Onodera S; Shibata A; Miura A; Suzuki A; Sakamoto S
    Saishin Igaku; 1969 May; 24(5):1113-7. PubMed ID: 4185953
    [No Abstract]   [Full Text] [Related]  

  • 77. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C; Gilbert D; Brard F; Tron F
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Photometric evaluation of indirect immunofluorescence chessboard titrations for the characterization of FITC-labelled antibodies.
    Albini B; Herzog F; Wick G
    Immunology; 1972 Sep; 23(3):343-54. PubMed ID: 4139109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immunofluorescence on Crithidia luciliae in the detection of anti-native DNA antibodies (author's transl)].
    André C; Villeminot S; Bourhala S
    Nouv Presse Med; 1982 Apr; 11(15):1127-30. PubMed ID: 7043393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.